000 01060 a2200349 4500
005 20250513112856.0
264 0 _c19970404
008 199704s 0 0 eng d
022 _a1061-4036
024 7 _a10.1038/ng0397-226
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBishop, D T
245 0 0 _aAT-tributable risks?
_h[electronic resource]
260 _bNature genetics
_cMar 1997
300 _a226 p.
_bdigital
500 _aPublication Type: News; Comment
650 0 4 _aBRCA1 Protein
_xgenetics
650 0 4 _aBRCA2 Protein
650 0 4 _aBreast Neoplasms
_xepidemiology
650 0 4 _aConfidence Intervals
650 0 4 _aFemale
650 0 4 _aGene Frequency
650 0 4 _aGenetic Carrier Screening
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aRisk Factors
650 0 4 _aTranscription Factors
_xgenetics
700 1 _aHopper, J
773 0 _tNature genetics
_gvol. 15
_gno. 3
_gp. 226
856 4 0 _uhttps://doi.org/10.1038/ng0397-226
_zAvailable from publisher's website
999 _c9043077
_d9043077